A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT07129382 · RECRUITING
Trial details
- NCT number
- NCT07129382
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2027-09-18
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.